Advertisement
Home Tags Screening

Tag: Screening

Introduction of genomic screening into routine health care is dependent on demonstration of clinical utility

Demonstrating Clinical Use Will Speed Genomic Screening

0
Field could advance more quickly if data from research participants, consumers got to clinic
A new initiative to increase hepatitis B virus vaccination rates among at-risk adults has been developed

NFID Initiative Working to Up Hepatitis B Vaccination Rates

0
National Foundation for Infectious Diseases working to increase screening, vaccination in those at risk
The Ten Questions screen is an effective way to screen HIV-positive children for neurodevelopmental problems in resource-poor areas

Ten Questions Screen Helps ID Disability in HIV+ Children

0
Study shows it effectively IDs neurodevelopmental problems in resource-poor areas
The first blood test to detect melanoma skin cancer in its early stages has been created

Australian Researchers Develop First Blood Test for Melanoma

0
10 autoantibody biomarkers together display high sensitivity, specificity
Immediate monitoring with a self-applied wearable electrocardiogram patch results in a higher rate of atrial fibrillation diagnosis among individuals at high risk

Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate

0
Immediate versus delayed monitoring results in increased a-fib diagnosis rate in high-risk individuals
Universal screening is the most effective strategy for hepatitis C virus in France

Universal Screening Best Strategy for Hepatitis C in France

0
Universal screening is cost-effective when treatment is initiated regardless of fibrosis stage
The U.S. Preventive Services Task Force concludes that there is currently insufficient evidence to assess the benefits and harms of screening for peripheral artery disease with the ankle branchial index in asymptomatic adults. These findings form the basis of a final recommendation statement published in the July 10 issue of the Journal of the American Medical Association.

USPSTF: Evidence Lacking for ABI for PAD Screen in Asymptomatic

0
No direct evidence, limited indirect evidence for benefits of PAD screening in asymptomatic population
The U.S. Preventive Services Task Force concludes that there is currently insufficient evidence to assess the benefits and harms of adding nontraditional risk factors to traditional cardiovascular disease risk assessment in asymptomatic adults. These findings form the basis for a final recommendation statement published online July 10 in the Journal of the American Medical Association.

USPSTF: Evidence Lacking for Nontraditional CVD Risk Factors

0
Insufficient evidence for adding to traditional CVD risk assessment in asymptomatic adults
Individual blood donations will no longer need to be tested for the Zika virus

FDA Drops Zika Testing for Blood Donors

0
Agency recommends moving away from testing each individual donation to testing pooled donations
Risk-stratified breast screening improves the cost-effectiveness of screening

Risk-Stratified Breast Cancer Screening Ups Cost-Effectiveness

0
Risk-stratified screening can reduce overdiagnosis and maintain benefits of screening